Ovid Therapeutics (OVID) Net Equity Issued and Repurchased (2019 - 2026)
Ovid Therapeutics' (OVID) quarterly Net Equity Issued and Repurchased came in at $2.4 million in Q1 2026, up 11000.68% on a QoQ basis from $21314.0 in Q4 2021.
Ovid Therapeutics (OVID) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
Ovid Therapeutics (OVID) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $2.4 million in Q1 2026.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 11100.68% YoY) and the FY2020 annual result came in at $46.7 million, up 109.68% from the prior year.
- Net Equity Issued and Repurchased grew to $2.4 million in Q1 2026, from $21314.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $2.4 million in Q1 2026 to a low of $2.4 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ovid Therapeutics | 385.37 Mn | 229.84 Mn | - | 2.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.37 Mn |
| Mar 31, 2026 | 2.37 Mn |
| Dec 31, 2021 | 21,314.00 |
| Dec 31, 2021 | 21,314.00 |
| Mar 31, 2021 | -21,314.00 |
| Mar 31, 2021 | -21,314.00 |
| Dec 31, 2020 | -221,065.00 |
| Dec 31, 2020 | -221,065.00 |
| Jun 30, 2020 | 8,368.00 |
| Jun 30, 2020 | 8,368.00 |
| Mar 31, 2020 | -67,575.00 |
| Mar 31, 2020 | -67,575.00 |
| Dec 31, 2019 | -8.23 Mn |
| Dec 31, 2019 | -8.23 Mn |
| Jun 30, 2019 | -391,885.00 |
| Jun 30, 2019 | -391,885.00 |
| Mar 31, 2019 | 30.91 Mn |
| Mar 31, 2019 | 30.91 Mn |